Table 1.
Patient characteristics and pathology
| Median age (range) | 63 (41–82) |
| <55 years | 31 (20%) |
| <45 years | 7 (5%) |
| Male-to-female ratio | 2.88 |
| ASA grade: | |
| 1 | 5 |
| 2 | 95 |
| 3 | 34 |
| Not recorded | 21 |
| Histopathology: | |
| Adenocarcinoma | 112 (72%) |
| Squamous cell carcinoma | 23 |
| Adenosquamous carcinoma | 4 |
| Leiomyoma | 3 |
| Gastrointestinal stromal tumour | 1 |
| High grade dysplasia | 1 |
| Other | 1 |
| Not recorded | 10 |
| Neoadjuvant chemotherapy | 112 (72%) |
| Unknown | 10 (6%) |
| Median length of tumour (range) | 4.4cm (1–15cm) |
| pTNM classification: | |
| T0 (complete response) | 8 |
| T1 | 21 |
| T2 | 44 |
| T3 | 63 |
| T4 | 3 |
| Benign | 6 |
| Data incomplete | 10 |
ASA = American Society of Anesthesiologists